Main description:

The Microbiology of Respiratory System Infections reviews modern approaches in the diagnosis, treatment, and prophylaxis of respiratory system infections. The book is very useful for researchers, scientists, academics, medical practitioners, graduate and postgraduate students, and specialists from pharmaceutical and laboratory diagnostic companies. The book has been divided into three sections according to the types of respiratory pathogens.

The first section contains reviews on the most common and epidemiologically important respiratory viruses, such as influenza virus, severe acute respiratory system coronavirus, and recently discovered Middle East respiratory syndrome coronavirus.

The second section is devoted to bacterial and fungal pathogens, which discusses etiology and pathogenesis including infections in patients with compromised immune system, and infections caused by fungal pathogens, such as Aspergillus and Pneumocystis.

The third section incorporates treatment approaches against different types of bacterial infections of the lower respiratory tract. This section reviews classical antimicrobial and phytomedical approaches as well as the application of nanotechnology against respiratory pathogens.

Contents:

Chapter 1: Influenza virus infections: clinical update, molecular biology, and therapeutic options

Chapter 2: Influenza viral infection in the respiratory system-potential ways of monitoring

Chapter 3: SARS coronavirus infections of the lower respiratory tract and their prevention

Chapter 4: The middle east respiratory syndrome coronavirus respiratory infection: an emerging infection from the arabian peninsula

Chapter 5: Respiratory infections of the human bocavirus

Chapter 6: Circulation of respiratory pathogens at mass gatherings, with special focus on the Hajj pilgrimage

Chapter 7: Indoor air pollution due to mycoflora causing acute lower respiratory infections

Chapter 8: Is there a link between environmental allergens and parasitism?

Chapter 9: Respiratory infections in immunosuppressed patients

Chapter 10: Metallo-beta-lactamase producer Pseudomonas aeruginosa: an opportunistic pathogen in lungs

Chapter 11: Mycobacterium tuberculosis: clinical and microbiological aspects

Chapter 12: Pulmonary aspergillosis: diagnosis and treatment

Chapter 13: Laboratory diagnosis of Pneumocystis jirovecii pneumonia

Chapter 14: Antimicrobial approaches against bacterial pathogens which cause lower respiratory system infections

Chapter 15: Nanotechnological applications for the control of pulmonary infections

Chapter 16: Volatile oils: Potential agents for the treatment of respiratory infections

Chapter 17: Current therapeutics and prophylactic approaches to treat pneumonia